These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1637608)

  • 1. EEG and auditory evoked potential P300 compared with psychometric tests in assessing vigilance after benzodiazepine sedation and antagonism.
    Engelhardt W; Friess K; Hartung E; Sold M; Dierks T
    Br J Anaesth; 1992 Jul; 69(1):75-80. PubMed ID: 1637608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acoustic and somatosensory evoked cortical potentials in sedation with midazolam and drug antagonism with flumazenil].
    Kochs E; Wüst P; Blanc I; Schulte am Esch J
    Anasth Intensivther Notfallmed; 1989 Feb; 24(1):49-56. PubMed ID: 2496619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of flumazenil on electroencephalographic patterns induced by midazolam.
    Wojna V; Guerrero L; Guzmán J; Cotto M
    P R Health Sci J; 2000 Dec; 19(4):353-6. PubMed ID: 11293887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of midazolam-induced EEG activation in rats by both flumazenil and hyperbaric oxygen.
    Russell GB; Vance WT; Graybeal JM
    J Neurosurg Anesthesiol; 1995 Oct; 7(4):271-9. PubMed ID: 8563448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophylline.
    Bonfiglio MF; Fisher-Katz LE; Saltis LM; Traeger SM; Martin BR; Nackes NA; Perkins TA
    Pharmacotherapy; 1996; 16(6):1166-72. PubMed ID: 8947991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects.
    Hotz MA; Ritz R; Linder L; Scollo-Lavizzari G; Haefeli WE
    Br J Clin Pharmacol; 2000 Jan; 49(1):72-9. PubMed ID: 10606840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flumazenil in intensive care. The duration of arousal after an assessment dose.
    Fisher GC; Clapham MC; Hutton P
    Anaesthesia; 1991 May; 46(5):413-6. PubMed ID: 2035797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physostigmine reversal of midazolam-induced electroencephalographic changes in healthy subjects.
    Ebert U; Oertel R; Kirch W
    Clin Pharmacol Ther; 2000 May; 67(5):538-48. PubMed ID: 10824633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
    Fiset P; Lemmens HL; Egan TD; Shafer SL; Stanski DR
    Clin Pharmacol Ther; 1995 Nov; 58(5):567-82. PubMed ID: 7586951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism by flumazenil of midazolam-induced changes in quantitative electroencephalographic data from isoflurane-anesthetized dogs.
    Keegan RD; Greene SA; Moore MP; Gallagher LV
    Am J Vet Res; 1993 May; 54(5):761-5. PubMed ID: 8317770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of central nervous system effects by flumazenil after intravenous conscious sedation with midazolam: report of a multicenter clinical study. The Flumazenil in Intravenous Conscious Sedation with Midazolam Multicenter Study Group I.
    Clin Ther; 1992; 14(6):861-77. PubMed ID: 1286495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flumazenil antagonizes the suppressive effect of midazolam on the somatosensory evoked potentials in the rat.
    Suzuki N; Hirose Y; Katakura N; Kubota Y
    Anesth Prog; 1991; 38(1):17-20. PubMed ID: 1809048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, controlled trial of cognitive and psychomotor recovery from midazolam sedation following reversal with oral flumazenil.
    Girdler NM; Lyne JP; Wallace R; Neave N; Scholey A; Wesnes KA; Herman C
    Anaesthesia; 2002 Sep; 57(9):868-76. PubMed ID: 12190751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impairment of the cognitive faculties and the reaction capability caused by midazolam despite reversal using flumazenil].
    Schlager A; Morawetz RF; Huber C; Furtwängler W; Luger TJ; Schreithofer D
    Anaesthesist; 1991 Jan; 40(1):33-8. PubMed ID: 2006724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of midazolam and flumazenil on psychomotor function and alertness in human volunteers.
    Coulthard P; Sano K; Thomson PJ; Macfarlane TV
    Br Dent J; 2000 Mar; 188(6):325-8. PubMed ID: 10800239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of flumazenil for reversing the effects of midazolam-induced conscious sedation or general anesthesia.
    Glass PS; Jhaveri RM; Ginsberg B; Ossey K
    South Med J; 1993 Nov; 86(11):1238-47. PubMed ID: 8235775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of midazolam and flumazenil on psychomotor function.
    Gupta A; Lind S; Eklund A; Lennmarken C
    J Clin Anesth; 1997 Feb; 9(1):21-5. PubMed ID: 9051541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of central benzodiazepine effects by intravenous flumazenil after conscious sedation with midazolam and opioids: a multicenter clinical study. The Flumazenil in Intravenous Conscious Sedation with Midazolam Multicenter Study Group II.
    Clin Ther; 1992; 14(6):878-94. PubMed ID: 1286496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ketamine racemate or S-(+)-ketamine and midazolam. The effect on vigilance, efficacy and subjective findings].
    Doenicke A; Kugler J; Mayer M; Angster R; Hoffmann P
    Anaesthesist; 1992 Oct; 41(10):610-8. PubMed ID: 1443509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of midazolam and flumazenil in diagnostic and short surgical procedures.
    Whitwam JG
    Acta Anaesthesiol Scand Suppl; 1990; 92():16-20; discussion 47. PubMed ID: 2109463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.